|
Aug 13
|
[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Aug 13
|
Illumina’s Q2 Earnings Call: Our Top 5 Analyst Questions
|
|
Aug 13
|
ILMN Q2 Deep Dive: Clinical Demand Cushions Revenue Decline Amid Research Weakness and Margin Pressures
|
|
Aug 13
|
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Aug 12
|
GRAIL Reports Second Quarter 2025 Financial Results
|
|
Aug 12
|
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know
|
|
Aug 12
|
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche
|
|
Aug 11
|
Standard BioTools Reports Second Quarter 2025 Financial Results
|
|
Aug 5
|
Illumina (ILMN) Reliance on International Sales: What Investors Need to Know
|
|
Aug 5
|
Does Illumina (ILMN) have an Attractive Risk-Reward Opportunity for Long-Term Investors?
|
|
Aug 4
|
Is Illumina, Inc. (NASDAQ:ILMN) Potentially Undervalued?
|
|
Aug 4
|
Illumina Second Quarter 2025 Earnings: EPS Beats Expectations
|
|
Aug 2
|
Illumina: Will big Pharma come to its rescue? Its CEO thinks so.
|
|
Aug 1
|
Top Technology Executives Recognized at the 2025 Minnesota ORBIE Awards
|
|
Aug 1
|
DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims
|
|
Jul 31
|
Compared to Estimates, Illumina (ILMN) Q2 Earnings: A Look at Key Metrics
|
|
Jul 31
|
Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates
|
|
Jul 31
|
Illumina (NASDAQ:ILMN) Surprises With Q2 Sales
|
|
Jul 31
|
Illumina: Q2 Earnings Snapshot
|
|
Jul 31
|
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
|